IT1255792B - Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda - Google Patents

Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda

Info

Publication number
IT1255792B
IT1255792B ITMI921930A ITMI921930A IT1255792B IT 1255792 B IT1255792 B IT 1255792B IT MI921930 A ITMI921930 A IT MI921930A IT MI921930 A ITMI921930 A IT MI921930A IT 1255792 B IT1255792 B IT 1255792B
Authority
IT
Italy
Prior art keywords
oral administration
pharmaceutical compositions
drink
dihydropyridins
compositions
Prior art date
Application number
ITMI921930A
Other languages
English (en)
Inventor
Gilberto Dondi
Silvana Ciceri
Paolo Scurati
Original Assignee
Bayer Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Italia Spa filed Critical Bayer Italia Spa
Priority to ITMI921930A priority Critical patent/IT1255792B/it
Publication of ITMI921930A0 publication Critical patent/ITMI921930A0/it
Priority to EP93111920A priority patent/EP0582169A3/de
Priority to US08/099,288 priority patent/US5491154A/en
Priority to CA002101680A priority patent/CA2101680A1/en
Priority to JP5209968A priority patent/JPH072700A/ja
Publication of ITMI921930A1 publication Critical patent/ITMI921930A1/it
Priority to US08/536,552 priority patent/US5622978A/en
Application granted granted Critical
Publication of IT1255792B publication Critical patent/IT1255792B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Si descrivono composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda.Tali composizioni sono caratterizzate dal contenere un coprecipitato di diidropiridina, sostanzialmente amorfa con un adatto polimero farmacologicamente accettabile. Si descrivono anche i relativi procedimenti di preparazione
ITMI921930A 1992-08-05 1992-08-05 Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda IT1255792B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ITMI921930A IT1255792B (it) 1992-08-05 1992-08-05 Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda
EP93111920A EP0582169A3 (en) 1992-08-05 1993-07-26 Pharmaceutical preparations for the oral administration of dihydropyridines in beverage form
US08/099,288 US5491154A (en) 1992-08-05 1993-07-29 Pharmaceutical preparation for the oral administration of dihydropyridines
CA002101680A CA2101680A1 (en) 1992-08-05 1993-07-30 Pharmaceutical preparations for the oral administration of dihydropyridines in beverage form
JP5209968A JPH072700A (ja) 1992-08-05 1993-08-03 ジヒドロピリジンの飲料の形態の経口投与用製薬学的組成物
US08/536,552 US5622978A (en) 1992-08-05 1995-09-29 Pharmaceutical preparations for the oral administration of dihydropyridines in beverage form

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI921930A IT1255792B (it) 1992-08-05 1992-08-05 Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda

Publications (3)

Publication Number Publication Date
ITMI921930A0 ITMI921930A0 (it) 1992-08-05
ITMI921930A1 ITMI921930A1 (it) 1994-02-05
IT1255792B true IT1255792B (it) 1995-11-16

Family

ID=11363839

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI921930A IT1255792B (it) 1992-08-05 1992-08-05 Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda

Country Status (5)

Country Link
US (2) US5491154A (it)
EP (1) EP0582169A3 (it)
JP (1) JPH072700A (it)
CA (1) CA2101680A1 (it)
IT (1) IT1255792B (it)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773025A (en) 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
AU695734B2 (en) 1996-07-08 1998-08-20 Penwest Pharmaceuticals Co. Sustained release matrix for high-dose insoluble drugs
EP1017366A4 (en) * 1996-09-01 2006-03-22 Pharmos Corp SOLID COPARCIPITATES FOR IMPROVED BIOVERABILITY OF LIPOPHILIC SUBSTANCES
US5891469A (en) * 1997-04-02 1999-04-06 Pharmos Corporation Solid Coprecipitates for enhanced bioavailability of lipophilic substances
US5989463A (en) 1997-09-24 1999-11-23 Alkermes Controlled Therapeutics, Inc. Methods for fabricating polymer-based controlled release devices
US6056977A (en) * 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
GB9920558D0 (en) * 1999-08-31 1999-11-03 Bradford Particle Design Ltd Methods for particle formation and their products
CA2352211C (en) 1999-09-30 2009-03-24 Edward Mendell Co., Inc. Sustained release matrix systems for highly soluble drugs
IL134701A0 (en) * 2000-02-23 2001-04-30 J P M E D Ltd Homogeneous solid matrix containing vegetable proteins
US6589955B2 (en) 2001-06-20 2003-07-08 Bristol-Myers Squibb Company Pediatric formulation of gatifloxacin
AU2002309172A1 (en) * 2001-06-22 2003-01-08 Pfizer Products Inc. Pharmaceutical compositions containing polymer and drug assemblies
WO2004043358A2 (en) * 2002-11-08 2004-05-27 Bristol-Myers Squibb Company Formulations of low solubility bioactive agents and processes for making the same
JP2007527394A (ja) * 2003-07-01 2007-09-27 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 拡散層調節固体
US7507823B2 (en) * 2004-05-06 2009-03-24 Bristol-Myers Squibb Company Process of making aripiprazole particles
TR201100152A2 (tr) * 2011-01-06 2012-07-23 Bi̇lgi̇ç Mahmut Amlodipin içeren efervesan bileşimler.
US9399019B2 (en) 2012-05-09 2016-07-26 Evonik Corporation Polymorph compositions, methods of making, and uses thereof
CN105596293A (zh) * 2016-01-29 2016-05-25 中国药科大学 一种脑靶向尼莫地平纳米混悬剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
DE1962791A1 (de) * 1969-12-15 1971-06-24 Boehringer Mannheim Gmbh Brausetabletten,Brausepulver und Verfahren zur Herstellung derselben
US4154839A (en) * 1975-11-05 1979-05-15 Bayer Aktiengesellschaft 2,6-Dimethyl-3-carboxymethoxy-4-(2-nitrophenyl)-5-carbisobutoxy-1,4-dihydropyridine
EP0001247A1 (en) * 1977-09-14 1979-04-04 Kanebo, Ltd. Pharmaceutical preparation containing nifedipine and a method for producing the same.
DE2815578C2 (de) * 1978-04-11 1986-01-16 Bayer Ag, 5090 Leverkusen Neue pharmazeutische Verwendung von Nimodipin
JPH0729926B2 (ja) * 1989-07-25 1995-04-05 大塚製薬株式会社 易吸収性製剤用組成物
GB9025251D0 (en) * 1990-11-20 1991-01-02 Solomon Montague C Nifedipine dosage forms

Also Published As

Publication number Publication date
US5491154A (en) 1996-02-13
US5622978A (en) 1997-04-22
EP0582169A3 (en) 1995-09-27
EP0582169A2 (de) 1994-02-09
CA2101680A1 (en) 1994-02-06
ITMI921930A1 (it) 1994-02-05
JPH072700A (ja) 1995-01-06
ITMI921930A0 (it) 1992-08-05

Similar Documents

Publication Publication Date Title
IT1255792B (it) Composizioni farmaceutiche per la somministrazione orale di diidropiridine in forma di bevanda
DK0810868T3 (da) Anvendelse af piperidin som et biotilgængelighedsforøgende middel
UA32525C2 (uk) Стійка до шлункового соку форма лікарського засобу на основі пантопразолу для орального введення
EP0873749A4 (en) GELLED PRODUCTS FOR ORAL ADMINISTRATION
ATE399171T1 (de) Camptothecinanaloge und deren zubereitungsmethoden
CA2239174A1 (en) Novel compounds with analgesic effect
DE60203894D1 (de) Herstellung von nichtkristallinem atorvastatin?calcium
YU21999A (sh) Farmaceutske smese i postupak za njihovo dobijanje
AR022254A1 (es) Composicion de administracion oral.
ITMI912212A0 (it) Composizioni farmaceutiche solide per somministrazione orale aventi proungata residenza gastrica
NO20014035L (no) System for oral administrasjon av medikament
IL89868A (en) Pharmaceutical compositions for oral administration, based on diphosphonic acid derivatives
DK0497158T3 (da) Farmaceutisk tyggegummi med acetylsalicylsyre
AU6945491A (en) Pimobendan compositions
NO178398C (no) Piperidin derivater og farmasöytisk formulering
EP0630260A4 (en) POLYSACCHARIDE-PROTEIN CONJUGATES.
EP0152273A3 (en) A phenylpiperidine derivative, and its salts, their preparation, compositions containing them, and their therapeutic use
HK1039273A1 (en) Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient
EP1285660A4 (en) ZINC SUPPLEMENTARY COMPOSITIONS FOR ORAL ADMINISTRATION
AU2907800A (en) Pharmaceutical composition containing desoxypeganine for the treatment of alcoholism
CA2129676A1 (en) Dextromethorphan Antitussive Compositions
IT1244373B (it) Composizioni farmaceutiche per uso orale contenenti eparina a basso peso molecolare, loro preparazione ed uso
ZW6789A1 (en) &-adrenergic receptor antagonists
ATE145333T1 (de) Hirudin enthaltende orale arzneimittel
AU8166291A (en) Method of treating mast cell disease

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970827